FBXO24 inhibitors are chemical compounds that specifically target the FBXO24 protein, a member of the F-box family of proteins. These proteins are characterized by the presence of an F-box motif, which typically functions as part of a larger SCF (Skp1-Cul1-F-box) ubiquitin ligase complex. The FBXO24 protein plays a role in recognizing and binding specific substrates that are subsequently marked for ubiquitination and proteasomal degradation. By inhibiting FBXO24, these compounds interfere with the normal regulatory pathways that control protein turnover within cells. This can lead to the accumulation of proteins normally targeted for degradation, thereby altering cellular homeostasis and potentially influencing various biochemical pathways related to protein dynamics and signaling.
Structurally, FBXO24 inhibitors are often designed to disrupt the interaction between FBXO24 and its substrate or the other components of the SCF complex. This may be achieved by binding directly to the F-box motif or adjacent domains critical for protein-protein interactions. These inhibitors can vary significantly in their chemical structures, encompassing small organic molecules, peptides, or modified peptides, depending on the specific interaction being targeted. The design of FBXO24 inhibitors often requires a detailed understanding of the protein's three-dimensional structure and its interactions with other proteins in the SCF complex. By selectively inhibiting FBXO24, researchers can gain insights into the biological role of this protein in cellular processes such as cell cycle regulation, signal transduction, and stress responses.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor, which could lead to the accumulation of SCF complex substrates, potentially influencing FBXO24 turnover. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is another proteasome inhibitor that may indirectly affect FBXO24 expression by disrupting the degradation of its substrates. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis, which could reduce the overall production of FBXO24. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA and inhibits RNA synthesis by RNA polymerase, potentially decreasing FBXO24 transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor that can alter chromatin structure and gene expression, including that of FBXO24. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can change gene methylation patterns, potentially affecting FBXO24 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Another DNA methyltransferase inhibitor that might change the methylation and expression of the FBXO24 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits the mTOR pathway, affecting protein synthesis regulation, which could suppress FBXO24 expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Causes premature termination of protein synthesis, potentially reducing the levels of proteins like FBXO24. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
A selective proteasome inhibitor that could affect the turnover of FBXO24 or its substrate proteins. | ||||||